The in vitro activity of Sch 29,482, a new oral P-lactam antimicrobial agent, was compared with those of norfloxacin, rosoxacin, ampicillin, erythromycin, and tetracycline against 142 Neisseria gonorrhoeae strains. Sch 29,482 was as active as norfloxacin and rosoxacin. Its activity was greater than the other three
antimicrobial agents. It inhibited 90% of the isolates, regardless of P-lactamase activity, at a concentration of <0.06 ,g/ml.
Sch 29,482 is a new oral P-lactam (penem) antimicrobial agent with a broad spectrum of antibacterial activity against both gram-negative and gram-positive bacteria (10) . It is stable to the action of most bacterial r-lactamases (10) . The purpose of our study was to evaluate the in vitro activity of Sch 29,482 against 3-lactamase-negative and ,B-lactamase-positive Neisseria atmosphere. The minimal inhibitory concentration was defined as the lowest concentration of the antimicrobial agent that inhibited visible growth on the agar surface.
The MICs for the six antimicrobial agents against N. gonorrhoeae are shown in Table 1 .
Sch 29,482 was highly active against both 3-lactamase-negative and -positive isolates; 90% of the isolates were inhibited by Sch 29,482 at a concentration of <0.06 ,ug/ml. Norfloxacin and rosoxacin were essentially equal to Sch 29,482 in activity against both N. gonorrhoeae groups.
The currently available oral antimicrobial agents erythromycin and tetracycline were less active than Sch 29,482, norfloxacin, and rosoxacin against both groups of isolates. Ampicillin inhibitory activity was dependent on P-lactamase production by N. gonorrhoeae. Good activity was demonstrated against P-lactamase-ANTIMICROB. AGENTS CHEMOTHER. We are grateful to Rosemary Pellegrini for typing the manuscript.
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